Literature DB >> 8406842

Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation.

M S de Souza1, A L Smith, D S Beck, L J Kim, G M Hansen, S W Barthold.   

Abstract

C3H/He mice inoculated intradermally at one of two sites with Borrelia burgdorferi responded differently to infection. Shoulder-inoculated mice developed spirochetemia, B. burgdorferi-specific antibody, and arthritis earlier than foot-inoculated mice. Lymphocyte populations derived from spleen tissue were elevated in the shoulder- but not the foot-inoculated mice, and those from lymph nodes were increased in both groups. Lymphocytes derived from blood and spleen tissue showed impaired proliferative responses to all mitogens for shoulder-inoculated mice only, whereas proliferation of lymph node cells was not affected, regardless of route. These results demonstrate that the site of initial B. burgdorferi inoculation is an important determinant in the pathogenesis of B. burgdorferi infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406842      PMCID: PMC281186          DOI: 10.1128/iai.61.10.4493-4497.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

2.  Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice.

Authors:  S W Barthold
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

3.  T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.

Authors:  A Krause; V Brade; C Schoerner; W Solbach; J R Kalden; G R Burmester
Journal:  Arthritis Rheum       Date:  1991-04

4.  Relationship of route of infection to susceptibility and immune response of inbred mice to Y strain Trypanosoma cruzi.

Authors:  D J Murfin; L Choromanski; R E Kuhn
Journal:  Am J Trop Med Hyg       Date:  1989-07       Impact factor: 2.345

5.  Infectious but nonpathogenic isolate of Borrelia burgdorferi.

Authors:  J F Anderson; S W Barthold; L A Magnarelli
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

6.  Lyme borreliosis in selected strains and ages of laboratory mice.

Authors:  S W Barthold; D S Beck; G M Hansen; G A Terwilliger; K D Moody
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

7.  Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.

Authors:  A Krause; G R Burmester; A Rensing; C Schoerner; U E Schaible; M M Simon; P Herzer; M D Kramer; R Wallich
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens.

Authors:  M S de Souza; E Fikrig; A L Smith; R A Flavell; S W Barthold
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

9.  Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.

Authors:  R Schoenfeld; B Araneo; Y Ma; L M Yang; J J Weis
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.

Authors:  A L Armstrong; S W Barthold; D H Persing; D S Beck
Journal:  Am J Trop Med Hyg       Date:  1992-08       Impact factor: 2.345

View more
  12 in total

1.  Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks.

Authors:  N Pusterla; C M Leutenegger; J S Chae; H Lutz; R B Kimsey; J S Dumler; J E Madigan
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Authors:  Flavia L Ribeiro-Gomes; Eric Henrique Roma; Matheus B H Carneiro; Nicole A Doria; David L Sacks; Nathan C Peters
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

3.  Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  T-helper-cell cytokines in the early evolution of murine Lyme arthritis.

Authors:  I Kang; S W Barthold; D H Persing; L K Bockenstedt
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Control of Borrelia burgdorferi-specific CD4+-T-cell effector function by interleukin-12- and T-cell receptor-induced p38 mitogen-activated protein kinase activity.

Authors:  Michael N Hedrick; Chris M Olson; Dietrich B Conze; Tonya C Bates; Mercedes Rincón; Juan Anguita
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection.

Authors:  Christine J Hastey; Rebecca A Elsner; Stephen W Barthold; Nicole Baumgarth
Journal:  J Immunol       Date:  2012-04-30       Impact factor: 5.422

7.  Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells.

Authors:  Charles R Brown; Victoria A Blaho; Christie M Loiacono
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Reinfection with Anaplasma phagocytophilum in BALB/c mice and cross-protection between two sympatric isolates.

Authors:  Michael L Levin; Dondrae J Coble; Danielle E Ross
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection.

Authors:  Michael E Woodman; Anne E Cooley; Jennifer C Miller; John J Lazarus; Kathryn Tucker; Tomasz Bykowski; Marina Botto; Jens Hellwage; R Mark Wooten; Brian Stevenson
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

10.  Lymphoadenopathy during lyme borreliosis is caused by spirochete migration-induced specific B cell activation.

Authors:  Stefan S Tunev; Christine J Hastey; Emir Hodzic; Sunlian Feng; Stephen W Barthold; Nicole Baumgarth
Journal:  PLoS Pathog       Date:  2011-05-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.